Find out how NAMs are influencing safety assessments and decision-making in the pharmaceutical industry ahead of 2026.

Find out how AI influences drug discovery, enabling earlier predictions and reducing the risks in clinical development.

Illumina, Inc. (NASDAQ: ILMN) today introduced the world's largest genome-wide genetic perturbation dataset, being built to ...

High-resolution analytical platforms, proteomics-driven workflows, and expanding CRO outsourcing reshape strategic priorities ...

Large language models (LLMs) can be broadly applied across multiple key stages in drug development: (1) Target identification and drug screening. Llama-Gram, GPCR LLM, and ProtChat systems effectively ...

AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...

GUEST COMMENTARY—For millions of patients, the slow pace of drug discovery means years – sometimes decades – without effective treatments. Many diseases remain untreatable, not because they are rare ...

OutSee, a genomics and drug discovery company pioneering a unique AI-based predictive genomics approach to target discovery, today announced the closure of its £2.5 M seed funding round. The Company ...